| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernias, Diaphragmatic, Congenital | 6 | 2024 | 395 | 1.700 |
Why?
|
| Infant, Very Low Birth Weight | 4 | 2024 | 169 | 0.920 |
Why?
|
| Respiratory System Abnormalities | 1 | 2020 | 42 | 0.690 |
Why?
|
| Birth Weight | 4 | 2020 | 339 | 0.620 |
Why?
|
| Hypoglycemia | 1 | 2020 | 191 | 0.600 |
Why?
|
| Infant, Premature, Diseases | 14 | 2024 | 239 | 0.580 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2020 | 625 | 0.520 |
Why?
|
| Infant, Newborn | 38 | 2024 | 8114 | 0.450 |
Why?
|
| Mass Screening | 1 | 2020 | 787 | 0.450 |
Why?
|
| Bacteremia | 2 | 2008 | 405 | 0.360 |
Why?
|
| Infant, Low Birth Weight | 12 | 1995 | 167 | 0.360 |
Why?
|
| Gram-Negative Bacteria | 1 | 2008 | 67 | 0.310 |
Why?
|
| Trachea | 3 | 2024 | 201 | 0.300 |
Why?
|
| Neonatal Screening | 3 | 2020 | 184 | 0.300 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 86 | 0.300 |
Why?
|
| Bilirubin | 2 | 2020 | 121 | 0.290 |
Why?
|
| Fetoscopy | 3 | 2024 | 439 | 0.250 |
Why?
|
| Biliary Atresia | 2 | 2020 | 186 | 0.250 |
Why?
|
| Urine Specimen Collection | 1 | 2022 | 3 | 0.210 |
Why?
|
| Specimen Handling | 1 | 2022 | 140 | 0.200 |
Why?
|
| Airway Obstruction | 1 | 2023 | 165 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 8 | 1996 | 144 | 0.180 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 78 | 0.170 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2020 | 49 | 0.170 |
Why?
|
| Blood | 1 | 2000 | 105 | 0.170 |
Why?
|
| Bacteriological Techniques | 1 | 2000 | 87 | 0.160 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2000 | 93 | 0.160 |
Why?
|
| Catheterization, Central Venous | 1 | 2020 | 132 | 0.160 |
Why?
|
| Gestational Age | 5 | 2020 | 1137 | 0.150 |
Why?
|
| Catheterization, Peripheral | 1 | 2020 | 126 | 0.150 |
Why?
|
| Retrospective Studies | 9 | 2024 | 16069 | 0.150 |
Why?
|
| Humans | 44 | 2024 | 123262 | 0.150 |
Why?
|
| Positive-Pressure Respiration | 1 | 1998 | 82 | 0.150 |
Why?
|
| Anuria | 1 | 2017 | 13 | 0.140 |
Why?
|
| Myotonic Dystrophy | 1 | 1998 | 148 | 0.130 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2017 | 133 | 0.130 |
Why?
|
| Prognosis | 3 | 2024 | 4511 | 0.130 |
Why?
|
| Oxygen | 1 | 2017 | 550 | 0.110 |
Why?
|
| Immunization, Passive | 2 | 1990 | 119 | 0.100 |
Why?
|
| Texas | 4 | 2020 | 3558 | 0.100 |
Why?
|
| Pregnancy | 7 | 2024 | 7129 | 0.100 |
Why?
|
| Cross Infection | 4 | 1999 | 330 | 0.100 |
Why?
|
| Female | 20 | 2024 | 65618 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2020 | 3336 | 0.090 |
Why?
|
| Infection Control | 2 | 1999 | 160 | 0.090 |
Why?
|
| Agammaglobulinemia | 1 | 1990 | 39 | 0.090 |
Why?
|
| Hypoplastic Left Heart Syndrome | 3 | 1999 | 252 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 1342 | 0.080 |
Why?
|
| Staphylococcal Infections | 3 | 2009 | 553 | 0.080 |
Why?
|
| Male | 20 | 2024 | 60334 | 0.080 |
Why?
|
| Predictive Value of Tests | 3 | 2020 | 2114 | 0.080 |
Why?
|
| Fatty Alcohols | 3 | 1995 | 5 | 0.080 |
Why?
|
| Phosphorylcholine | 3 | 1995 | 26 | 0.080 |
Why?
|
| Intubation, Intratracheal | 2 | 2024 | 291 | 0.080 |
Why?
|
| Pulmonary Surfactants | 3 | 1995 | 43 | 0.080 |
Why?
|
| Polyethylene Glycols | 3 | 1995 | 221 | 0.070 |
Why?
|
| Adjuvants, Immunologic | 1 | 2008 | 376 | 0.070 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 1999 | 315 | 0.070 |
Why?
|
| Infant | 7 | 2024 | 12376 | 0.060 |
Why?
|
| Indomethacin | 3 | 1996 | 84 | 0.060 |
Why?
|
| Hyaline Membrane Disease | 2 | 1982 | 4 | 0.060 |
Why?
|
| Sensitivity and Specificity | 3 | 2020 | 2019 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2023 | 904 | 0.060 |
Why?
|
| Airway Management | 1 | 2024 | 66 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 2024 | 31 | 0.060 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 4 | 1995 | 79 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 1 | 2009 | 1010 | 0.050 |
Why?
|
| Lung Volume Measurements | 1 | 2023 | 74 | 0.050 |
Why?
|
| Incidence | 3 | 2008 | 3054 | 0.050 |
Why?
|
| Prenatal Care | 2 | 2023 | 344 | 0.050 |
Why?
|
| Ductus Arteriosus, Patent | 3 | 1996 | 145 | 0.050 |
Why?
|
| Umbilical Veins | 1 | 2020 | 71 | 0.040 |
Why?
|
| Drug Administration Schedule | 2 | 2000 | 726 | 0.040 |
Why?
|
| Short Bowel Syndrome | 1 | 1999 | 61 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 701 | 0.040 |
Why?
|
| Palliative Care | 3 | 1999 | 428 | 0.040 |
Why?
|
| Immunoglobulins | 2 | 1990 | 169 | 0.040 |
Why?
|
| Catheterization | 1 | 2020 | 237 | 0.040 |
Why?
|
| Influenza A virus | 1 | 1999 | 138 | 0.040 |
Why?
|
| Time-to-Treatment | 1 | 2020 | 186 | 0.040 |
Why?
|
| Ventilator Weaning | 1 | 1998 | 23 | 0.040 |
Why?
|
| Interprofessional Relations | 1 | 1999 | 144 | 0.040 |
Why?
|
| Syphilis, Congenital | 1 | 1998 | 28 | 0.040 |
Why?
|
| Serratia Infections | 1 | 1997 | 4 | 0.040 |
Why?
|
| Serratia marcescens | 1 | 1997 | 10 | 0.040 |
Why?
|
| Empyema, Pleural | 1 | 1997 | 23 | 0.040 |
Why?
|
| Prospective Studies | 5 | 2000 | 6030 | 0.040 |
Why?
|
| Risk Factors | 3 | 2008 | 10035 | 0.040 |
Why?
|
| Nose | 1 | 1998 | 92 | 0.040 |
Why?
|
| Decision Making | 2 | 1999 | 652 | 0.030 |
Why?
|
| Disease Outbreaks | 2 | 1996 | 321 | 0.030 |
Why?
|
| Lipids | 1 | 2020 | 513 | 0.030 |
Why?
|
| Pneumonia, Bacterial | 1 | 1997 | 76 | 0.030 |
Why?
|
| Pneumothorax | 1 | 1997 | 80 | 0.030 |
Why?
|
| Premedication | 1 | 1996 | 43 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 235 | 0.030 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 1996 | 63 | 0.030 |
Why?
|
| Streptococcus pyogenes | 1 | 1996 | 77 | 0.030 |
Why?
|
| Neurologic Examination | 3 | 1995 | 195 | 0.030 |
Why?
|
| Bone and Bones | 1 | 1998 | 263 | 0.030 |
Why?
|
| Infant, Premature | 4 | 1997 | 807 | 0.030 |
Why?
|
| Resource Allocation | 1 | 1996 | 52 | 0.030 |
Why?
|
| Double-Blind Method | 5 | 2009 | 1601 | 0.030 |
Why?
|
| Respiratory Insufficiency | 1 | 1998 | 231 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2024 | 12170 | 0.030 |
Why?
|
| Lung | 1 | 2023 | 1465 | 0.030 |
Why?
|
| Bronchopulmonary Dysplasia | 3 | 1996 | 187 | 0.030 |
Why?
|
| ROC Curve | 1 | 2017 | 558 | 0.030 |
Why?
|
| Disclosure | 1 | 1996 | 155 | 0.030 |
Why?
|
| Retinal Diseases | 3 | 1982 | 172 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 1999 | 644 | 0.030 |
Why?
|
| Liver Abscess | 1 | 1994 | 12 | 0.030 |
Why?
|
| Ganciclovir | 1 | 1994 | 102 | 0.030 |
Why?
|
| Streptococcal Infections | 1 | 1996 | 244 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 2811 | 0.030 |
Why?
|
| Influenza, Human | 1 | 1999 | 652 | 0.030 |
Why?
|
| Health Status | 1 | 1995 | 375 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 1996 | 395 | 0.030 |
Why?
|
| Child Development | 1 | 1995 | 260 | 0.030 |
Why?
|
| Candidiasis | 1 | 1994 | 129 | 0.030 |
Why?
|
| Dexamethasone | 1 | 1994 | 271 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1992 | 81 | 0.020 |
Why?
|
| Adenovirus Infections, Human | 1 | 1992 | 49 | 0.020 |
Why?
|
| Cytomegalovirus Infections | 1 | 1994 | 217 | 0.020 |
Why?
|
| Escherichia coli Infections | 1 | 1994 | 190 | 0.020 |
Why?
|
| Liver Transplantation | 1 | 2020 | 1022 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 3384 | 0.020 |
Why?
|
| Time Factors | 2 | 2000 | 6223 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 2 | 2000 | 2398 | 0.020 |
Why?
|
| Drug Combinations | 4 | 1995 | 268 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 1990 | 263 | 0.020 |
Why?
|
| Retinopathy of Prematurity | 2 | 1995 | 56 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 2953 | 0.020 |
Why?
|
| Virus Diseases | 1 | 1990 | 279 | 0.020 |
Why?
|
| Respiratory Tract Infections | 1 | 1990 | 264 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 1996 | 1099 | 0.020 |
Why?
|
| Heart Transplantation | 3 | 1999 | 854 | 0.020 |
Why?
|
| Counseling | 2 | 1999 | 219 | 0.020 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 1986 | 93 | 0.020 |
Why?
|
| Dipeptidases | 1 | 1985 | 14 | 0.020 |
Why?
|
| Thienamycins | 1 | 1985 | 14 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 1995 | 5056 | 0.010 |
Why?
|
| Cyclopropanes | 1 | 1985 | 67 | 0.010 |
Why?
|
| DNA, Viral | 2 | 1999 | 479 | 0.010 |
Why?
|
| Education, Special | 1 | 1983 | 11 | 0.010 |
Why?
|
| Social Class | 1 | 1983 | 190 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 1996 | 1414 | 0.010 |
Why?
|
| Disabled Persons | 1 | 1983 | 99 | 0.010 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 1982 | 8 | 0.010 |
Why?
|
| Vitamin E | 1 | 1981 | 65 | 0.010 |
Why?
|
| Methicillin | 1 | 1981 | 43 | 0.010 |
Why?
|
| Cerebral Palsy | 1 | 1982 | 80 | 0.010 |
Why?
|
| Infant, Small for Gestational Age | 1 | 1980 | 49 | 0.010 |
Why?
|
| Spasms, Infantile | 1 | 1982 | 171 | 0.010 |
Why?
|
| Adult | 2 | 1998 | 29100 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1999 | 113 | 0.010 |
Why?
|
| Hospitals, Urban | 1 | 1999 | 98 | 0.010 |
Why?
|
| Nasopharynx | 1 | 1999 | 80 | 0.010 |
Why?
|
| Hydrocephalus | 1 | 1982 | 242 | 0.010 |
Why?
|
| Neonatology | 1 | 1999 | 51 | 0.010 |
Why?
|
| Injections, Intravenous | 2 | 1990 | 254 | 0.010 |
Why?
|
| Drug Evaluation | 2 | 1990 | 111 | 0.010 |
Why?
|
| Hypercapnia | 1 | 1978 | 20 | 0.010 |
Why?
|
| Osteomyelitis | 1 | 1981 | 204 | 0.010 |
Why?
|
| Quality of Life | 2 | 1999 | 1933 | 0.010 |
Why?
|
| Surveys and Questionnaires | 2 | 1999 | 3677 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 1981 | 455 | 0.010 |
Why?
|
| Child, Preschool | 2 | 1983 | 13918 | 0.010 |
Why?
|
| Gastroenterology | 1 | 1999 | 191 | 0.010 |
Why?
|
| Echocardiography | 2 | 1996 | 1049 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 1289 | 0.010 |
Why?
|
| Personnel, Hospital | 1 | 1996 | 34 | 0.010 |
Why?
|
| Pharynx | 1 | 1996 | 64 | 0.010 |
Why?
|
| Serotyping | 1 | 1996 | 178 | 0.010 |
Why?
|
| Infant, Newborn, Diseases | 1 | 1978 | 170 | 0.010 |
Why?
|
| Intellectual Disability | 1 | 1983 | 1047 | 0.010 |
Why?
|
| Technology, High-Cost | 1 | 1996 | 3 | 0.010 |
Why?
|
| Carrier State | 1 | 1996 | 77 | 0.010 |
Why?
|
| Cerebral Ventricles | 1 | 1996 | 81 | 0.010 |
Why?
|
| Financing, Organized | 1 | 1996 | 19 | 0.010 |
Why?
|
| Parental Consent | 1 | 1996 | 23 | 0.010 |
Why?
|
| Beneficence | 1 | 1996 | 81 | 0.010 |
Why?
|
| Radiography | 1 | 1998 | 822 | 0.010 |
Why?
|
| Health Care Rationing | 1 | 1996 | 58 | 0.010 |
Why?
|
| Air | 1 | 1995 | 26 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 1996 | 353 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 1996 | 474 | 0.010 |
Why?
|
| Xanthomonas | 1 | 1994 | 5 | 0.010 |
Why?
|
| Malassezia | 1 | 1994 | 7 | 0.010 |
Why?
|
| Cardiology | 1 | 1999 | 474 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 1995 | 182 | 0.010 |
Why?
|
| Family | 1 | 1996 | 567 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1995 | 372 | 0.010 |
Why?
|
| Logistic Models | 1 | 1996 | 1801 | 0.010 |
Why?
|
| Respiration, Artificial | 1 | 1994 | 458 | 0.010 |
Why?
|
| Adenoviridae Infections | 1 | 1990 | 70 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1990 | 143 | 0.010 |
Why?
|
| Risk | 2 | 1981 | 747 | 0.000 |
Why?
|
| Cohort Studies | 1 | 1998 | 4701 | 0.000 |
Why?
|
| Parents | 1 | 1996 | 1032 | 0.000 |
Why?
|
| Cause of Death | 1 | 1990 | 463 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 176 | 0.000 |
Why?
|
| Survival Rate | 1 | 1990 | 2002 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1990 | 1080 | 0.000 |
Why?
|
| Cilastatin | 1 | 1985 | 1 | 0.000 |
Why?
|
| Imipenem | 1 | 1985 | 9 | 0.000 |
Why?
|
| Immunoglobulin G | 1 | 1988 | 768 | 0.000 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1985 | 339 | 0.000 |
Why?
|
| Recurrence | 1 | 1987 | 1418 | 0.000 |
Why?
|
| Kinetics | 1 | 1985 | 1318 | 0.000 |
Why?
|
| Penicillin Resistance | 1 | 1981 | 80 | 0.000 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 1981 | 91 | 0.000 |
Why?
|
| United States | 1 | 1996 | 10654 | 0.000 |
Why?
|
| Cicatrix | 1 | 1981 | 125 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1981 | 671 | 0.000 |
Why?
|
| Asphyxia Neonatorum | 1 | 1978 | 15 | 0.000 |
Why?
|
| Lactates | 1 | 1978 | 93 | 0.000 |
Why?
|
| Apgar Score | 1 | 1978 | 47 | 0.000 |
Why?
|
| Bicarbonates | 1 | 1978 | 98 | 0.000 |
Why?
|
| Acid-Base Equilibrium | 1 | 1978 | 59 | 0.000 |
Why?
|
| Umbilical Arteries | 1 | 1978 | 88 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1978 | 425 | 0.000 |
Why?
|
| Carbon Dioxide | 1 | 1978 | 273 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1981 | 1084 | 0.000 |
Why?
|
| Sepsis | 1 | 1981 | 476 | 0.000 |
Why?
|
| Cerebrovascular Circulation | 1 | 1978 | 430 | 0.000 |
Why?
|